A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses.

Life Science Alliance
Huan DuFenghua Hu

Abstract

Haploinsufficiency of progranulin (PGRN) is a leading cause of frontotemporal lobar degeneration (FTLD). PGRN polymorphisms are associated with Alzheimer's disease. PGRN is highly expressed in the microglia near Aβ plaques and influences plaque dynamics and microglial activation. However, the detailed mechanisms remain elusive. Here we report that PGRN deficiency reduces human APP and Aβ levels in the young male but not female mice. PGRN-deficient microglia exhibit increased expression of markers associated with microglial activation, including CD68, galectin-3, TREM2, and GPNMB, specifically near Aβ plaques. In addition, PGRN loss leads to up-regulation of lysosome proteins and an increase in the nuclear localization of TFE3, a transcription factor involved in lysosome biogenesis. Cultured PGRN-deficient microglia show enhanced nuclear translocation of TFE3 and inflammation in response to Aβ fibril treatment. Taken together, our data revealed a sex- and age-dependent effect of PGRN on APP metabolism and a role of PGRN in regulating lysosomal activities and inflammation in plaque-associated microglia.

References

Apr 8, 1998·Neuroscience Letters·M SuzukiM Takahashi
Dec 18, 2001·Journal of Cellular Biochemistry·F F SafadiS N Popoff
Feb 5, 2002·Molecular Genetics and Metabolism·Masatoshi Suzuki, Masugi Nishiahara
Sep 5, 2006·Human Molecular Genetics·Jennifer GassRosa Rademakers
Dec 21, 2006·The Journal of Reproduction and Development·Shuichi ChibaMasugi Nishihara
Sep 4, 2007·Behavioural Brain Research·Yuko KayasugaMasugi Nishihara
Oct 30, 2007·Nature Neuroscience·Uwe-Karsten Hanisch, Helmut Kettenmann
Jan 11, 2008·Neurology·K SleegersC Van Broeckhoven
Mar 25, 2008·Protein Science : a Publication of the Protein Society·Dmitri TolkatchevFeng Ni
Nov 20, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jayashree ViswanathanMikko Hiltunen
Jun 27, 2009·The Journal of Pathology·Sandra PeresonSamir Kumar-Singh
Sep 2, 2009·The Journal of Reproduction and Development·Masatoshi SuzukiMasugi Nishihara
Oct 2, 2009·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Andrew Bateman, Hugh P J Bennett
Dec 1, 2009·Acta Neuropathologica·Swati B NaphadeJeff Kuret
Dec 23, 2009·The Journal of Experimental Medicine·Fangfang YinAihao Ding
Nov 5, 2010·Journal of the Neurological Sciences·Ging-Yuek R HsiungIan R A Mackenzie
Nov 26, 2010·Journal of Neuropathology and Experimental Neurology·Thomas PhilipsPhilip Van Damme
Jan 13, 2011·The American Journal of Pathology·Fiona PickfordMichael Hutton
Aug 16, 2011·Journal of Visualized Experiments : JoVE·Philip T T LyWeihong Song
Nov 9, 2011·Neurobiology of Disease·Terri L PetkauBlair R Leavitt
Jan 27, 2012·Alzheimer's Research & Therapy·Alexandra M NicholsonRosa Rademakers
May 23, 2012·American Journal of Human Genetics·Katherine R SmithSamuel F Berkovic
Aug 15, 2012·Journal of Alzheimer's Disease : JAD·Anna KämäläinenMikko Hiltunen
Oct 9, 2012·The Journal of Clinical Investigation·Lauren Herl MartensRobert V Farese
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Feb 12, 2013·Journal of Alzheimer's Disease : JAD·Paola PiscopoAnnamaria Confaloni
Apr 24, 2013·JAMA Neurology·David C PerryGil Rabinovici
Feb 4, 2014·Genome Biology·Charity W LawGordon K Smyth
Feb 18, 2014·The Journal of Biological Chemistry·Kassandra Weber, Joel D Schilling
Jun 26, 2014·Nature Reviews. Immunology·Michael T HenekaEicke Latz
Jul 16, 2014·Acta Neuropathologica Communications·Yoshinori TanakaMasugi Nishihara
Sep 28, 2014·Bioinformatics·Simon AndersWolfgang Huber
Jul 1, 2015·Proceedings of the National Academy of Sciences of the United States of America·Swetha GowrishankarShawn M Ferguson
Sep 16, 2015·The Journal of Cell Biology·Xiaolai ZhouFenghua Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.